Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Characteristics of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Taking Injectable and Oral Disease Modifying Treatments (Dmt) In Europe (Eu).
Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis.
Whole Transcriptome Screening Reveals Myelination Deficits in Dysplastic Human Temporal Neocortex.
Prevalence and risk factors for depression in women with multiple sclerosis: a study from Iran.
"Microglial nodules" and "newly forming lesions" may be a Janus face of early MS lesions; implications from virus-induced demyelination, the Inside-Out model.
Eye and hand motor interactions with the Symbol Digit Modalities Test in early multiple sclerosis.
Clinical 3-tesla FLAIR* MRI improves diagnostic accuracy in multiple sclerosis.
Long-term effects of intrathecal baclofen in multiple sclerosis.
Subretinal angiostrongyliasis-induced optic neuritis.
Principal components of functional connectivity: A new approach to study dynamic brain connectivity during rest.
Gray Matter Pathology in MS: Neuroimaging and Clinical Correlations.
Cerebrospinal fluid derived from progressive multiple sclerosis patients promotes neuronal and oligodendroglial differentiation of human neural precursor cells in vitro.
The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach.
Active Cognitive Reserve Influences the Regional Atrophy to Cognition Link in Multiple Sclerosis.
CD4(+)NKG2D(+) T Cells Exhibit Enhanced Migratory and Encephalitogenic Properties in Neuroinflammation.
Comparison of diabetes patients with "demyelinating" diabetic sensorimotor polyneuropathy to those diagnosed with CIDP.
Aquaporin-4 immuneglobulin g testing in 36 consecutive jamaican patients with inflammatory central nervous system demyelinating disease.
Blocking GluR2-GAPDH ameliorates experimental autoimmune encephalomyelitis.
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis.
[Diagnosis and monitoring of multiple sclerosis : The value of optical coherence tomography.]
Immunoenrichment microwave & magnetic (IM(2) ) proteomics for quantifying CD47 in the EAE model of multiple sclerosis.
Boswellic acids reduce TH17 differentiation via blockade of IL-1β-Mediated IRAK1 signaling.
The current role of mitoxantrone in the treatment of multiple sclerosis.
Molecular mechanisms of scar-sourced axon growth inhibitors.
Intensity of treadmill walking exercise on acute mood symptoms in persons with multiple sclerosis.
Pages
« first
‹ previous
…
590
591
592
593
594
595
596
597
598
…
next ›
last »